Infinity Pharma (INFI) Ticks Lower on Dilutive Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Infinity Pharma (INFI) Announces Public Common Offering
December 12, 2012 4:07 PM ESTInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by Infinity.
The joint book-running managers for the proposed offering are Morgan... More
